Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plans.

Daugherty MA, Hinman AR, Cochi SL, Garon JR, Rodewald LE, Nowak G, McKinlay MA, Mast EE, Orenstein WA.

Vaccine. 2019 Aug 14;37(35):4928-4936. doi: 10.1016/j.vaccine.2019.07.042. Epub 2019 Jul 17.

PMID:
31326253
2.

Hepatitis B Surface Antigen Seroprevalence among Prevaccine and Vaccine Era Children in Bangladesh.

Paul RC, Rahman M, Wiesen E, Patel M, Banik KC, Sharif AR, Sultana S, Rahman M, Liyanage J, Abeysinghe N, Kamili S, Murphy T, Luby SP, Mast EE.

Am J Trop Med Hyg. 2018 Sep;99(3):764-771. doi: 10.4269/ajtmh.17-0721. Epub 2018 Jul 12.

3.

Implications of a National Health Insurance Marketplace.

Mast EE.

J Am Osteopath Assoc. 2018 May 1;118(5):289-292. doi: 10.7556/jaoa.2018.043. No abstract available.

PMID:
29528369
4.

Fifty Years of Global Immunization at CDC, 1966-2015.

Mast EE, Cochi SL, Kew OM, Cairns KL, Bloland PB, Martin R.

Public Health Rep. 2017 Jan/Feb;132(1):18-26. doi: 10.1177/0033354916681490. Epub 2016 Dec 19. No abstract available.

5.

Possible eradication of wild poliovirus type 3--worldwide, 2012.

Kew OM, Cochi SL, Jafari HS, Wassilak SG, Mast EE, Diop OM, Tangermann RH, Armstrong GL; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Nov 14;63(45):1031-3.

6.

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.

Weinbaum CM, Mast EE, Ward JW.

Hepatology. 2009 May;49(5 Suppl):S35-44. doi: 10.1002/hep.22882.

PMID:
19399812
7.

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.

Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 Sep 19;57(RR-8):1-20.

8.

Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003.

Swerdlow DL, Roper MH, Morgan J, Schieber RA, Sperling LS, Sniadack MM, Neff L, Miller JW, Curtis CR, Marin ME, Iskander J, Moro P, Hightower P, Levine NH, McCauley M, Heffelfinger J, Damon I, Török TJ, Wharton M, Mast EE, Mootrey GT; Smallpox Vaccine Cardiac Adverse Events Working Group.

Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S234-41. doi: 10.1086/524745.

PMID:
18284364
9.

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Dec 8;55(RR-16):1-33; quiz CE1-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2007 Oct 26;56(42):1114.

10.

Hepatitis E: an overview.

Krawczynski K, Mast EE, Purdy MA.

Minerva Gastroenterol Dietol. 1999 Jun;45(2):119-30; discussion 130-5.

PMID:
16498322
11.

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.

Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2005 Dec 23;54(RR-16):1-31. Erratum in: MMWR Morb Mortal Wkly Rep. 2006 Feb 17;55(6):158-9. MMWR Morb Mortal Wkly Rep. 2007 Dec 7;56(48):1267.

12.

Adverse events associated with smallpox vaccination in the United States, January-October 2003.

Casey CG, Iskander JK, Roper MH, Mast EE, Wen XJ, Török TJ, Chapman LE, Swerdlow DL, Morgan J, Heffelfinger JD, Vitek C, Reef SE, Hasbrouck LM, Damon I, Neff L, Vellozzi C, McCauley M, Strikas RA, Mootrey G.

JAMA. 2005 Dec 7;294(21):2734-43.

PMID:
16333009
13.

Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy.

Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, Alter MJ.

J Infect Dis. 2005 Dec 1;192(11):1880-9. Epub 2005 Oct 28.

PMID:
16267758
14.

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS.

Int J Epidemiol. 2005 Dec;34(6):1329-39. Epub 2005 Oct 25.

PMID:
16249217
15.

Prevention of hepatitis C in women.

Bell BP, Mast EE, Terrault N, Hutin YJ.

Emerg Infect Dis. 2004 Nov;10(11):2035-6. No abstract available.

16.

Mother-to-infant hepatitis C virus transmission and breastfeeding.

Mast EE.

Adv Exp Med Biol. 2004;554:211-6. Review.

PMID:
15384578
17.

Injection practices in Romania: progress and challenges.

Dentinger C, Pasat L, Popa M, Hutin YJ, Mast EE.

Infect Control Hosp Epidemiol. 2004 Jan;25(1):30-5.

PMID:
14756216
18.

Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001.

Griffith KS, Mead P, Armstrong GL, Painter J, Kelley KA, Hoffmaster AR, Mayo D, Barden D, Ridzon R, Parashar U, Teshale EH, Williams J, Noviello S, Perz JF, Mast EE, Swerdlow DL, Hadler JL.

Emerg Infect Dis. 2003 Jun;9(6):681-8.

19.

Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001.

Williams AA, Parashar UD, Stoica A, Ridzon R, Kirschke DL, Meyer RF, McClellan J, Fischer M, Nelson R, Cartter M, Hadler JL, Jernigan JA, Mast EE, Swerdlow DL; Connecticut Anthrax Investigation Team.

Emerg Infect Dis. 2002 Oct;8(10):1078-82.

20.

Fatal inhalational anthrax in a 94-year-old Connecticut woman.

Barakat LA, Quentzel HL, Jernigan JA, Kirschke DL, Griffith K, Spear SM, Kelley K, Barden D, Mayo D, Stephens DS, Popovic T, Marston C, Zaki SR, Guarner J, Shieh WJ, Carver HW 2nd, Meyer RF, Swerdlow DL, Mast EE, Hadler JL; Anthrax Bioterrorism Investigation Team.

JAMA. 2002 Feb 20;287(7):863-8.

PMID:
11851578
21.

Hepatitis E virus antibody prevalence among persons who work with swine.

Drobeniuc J, Favorov MO, Shapiro CN, Bell BP, Mast EE, Dadu A, Culver D, Iarovoi P, Robertson BH, Margolis HS.

J Infect Dis. 2001 Dec 15;184(12):1594-7. Epub 2001 Dec 3.

PMID:
11740735
22.

Hepatitis B vaccination coverage among United States children.

Yusuf H, Daniels D, Mast EE, Coronado V.

Pediatr Infect Dis J. 2001 Nov;20(11 Suppl):S30-3.

PMID:
11704721
23.

Childhood hepatitis B virus infections in the United States before hepatitis B immunization.

Armstrong GL, Mast EE, Wojczynski M, Margolis HS.

Pediatrics. 2001 Nov;108(5):1123-8.

PMID:
11694691
24.

Preventing transmission of hepatitis B virus from people with chronic infection.

Weinberg MS, Gunn RA, Mast EE, Gresham L, Ginsberg M.

Am J Prev Med. 2001 May;20(4):272-6.

PMID:
11331115
25.

The economics of vaccinating restaurant workers against hepatitis A.

Meltzer MI, Shapiro CN, Mast EE, Arcari C.

Vaccine. 2001 Feb 28;19(15-16):2138-45.

PMID:
11228386
26.

Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus.

Li TC, Zhang J, Shinzawa H, Ishibashi M, Sata M, Mast EE, Kim K, Miyamura T, Takeda N.

J Med Virol. 2000 Nov;62(3):327-33.

PMID:
11055242
27.

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.

Sulkowski MS, Mast EE, Seeff LB, Thomas DL.

Clin Infect Dis. 2000 Apr;30 Suppl 1:S77-84. Review.

PMID:
10770916
28.

An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis.

Hutin YJ, Goldstein ST, Varma JK, O'Dair JB, Mast EE, Shapiro CN, Alter MJ.

Infect Control Hosp Epidemiol. 1999 Nov;20(11):731-5.

PMID:
10580622
29.

Strategies to prevent and control hepatitis B and C virus infections: a global perspective.

Mast EE, Alter MJ, Margolis HS.

Vaccine. 1999 Mar 26;17(13-14):1730-3. Review.

PMID:
10194830
30.

Hepatitis C: Part II. Prevention counseling and medical evaluation.

Moyer LA, Mast EE, Alter MJ.

Am Fam Physician. 1999 Jan 15;59(2):349-54, 357. Review.

31.

Hepatitis C: Part I. Routine serologic testing and diagnosis.

Moyer LA, Mast EE, Alter MJ.

Am Fam Physician. 1999 Jan 1;59(1):79-88, 91-2. Review.

32.

Progress toward elimination of hepatitis B virus transmission in the United States.

Mast EE, Mahoney FJ, Alter MJ, Margolis HS.

Vaccine. 1998 Nov;16 Suppl:S48-51. Review.

PMID:
9915035
33.

Hepatitis B vaccination of adolescent and adult high-risk groups in the United States.

Mast EE, Williams IT, Alter MJ, Margolis HS.

Vaccine. 1998 Nov;16 Suppl:S27-9. Review.

PMID:
9915029
34.

Prevaccination screening for hepatitis B among sexually active adolescents and young adults.

Buffington J, Mast EE.

Clin Infect Dis. 1998 Dec;27(6):1562-3. No abstract available.

PMID:
9868699
35.

Hepatitis A through E.

Moyer LA, Mast EE.

J Intraven Nurs. 1998 Sep-Oct;21(5):286-90. Review.

PMID:
9814282
36.
37.

Hepatitis C.

Alter MJ, Mast EE, Moyer LA, Margolis HS.

Infect Dis Clin North Am. 1998 Mar;12(1):13-26. Review.

PMID:
9494826
38.

Acute hepatitis E by a new isolate acquired in the United States.

Kwo PY, Schlauder GG, Carpenter HA, Murphy PJ, Rosenblatt JE, Dawson GJ, Mast EE, Krawczynski K, Balan V.

Mayo Clin Proc. 1997 Dec;72(12):1133-6.

PMID:
9413292
39.

Prevention of infectious disease transmission in sports.

Mast EE, Goodman RA.

Sports Med. 1997 Jul;24(1):1-7. Review.

PMID:
9257406
40.

Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California.

Mast EE, Kuramoto IK, Favorov MO, Schoening VR, Burkholder BT, Shapiro CN, Holland PV.

J Infect Dis. 1997 Jul;176(1):34-40.

PMID:
9207347
41.

Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study.

Bresee JS, Mast EE, Coleman PJ, Baron MJ, Schonberger LB, Alter MJ, Jonas MM, Yu MY, Renzi PM, Schneider LC.

JAMA. 1996 Nov 20;276(19):1563-7.

PMID:
8918853
42.

IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein.

Favorov MO, Khudyakov YE, Mast EE, Yashina TL, Shapiro CN, Khudyakova NS, Jue DL, Onischenko GG, Margolis HS, Fields HA.

J Med Virol. 1996 Sep;50(1):50-8.

PMID:
8890041
43.

Hepatitis E.

Mast EE, Purdy MA, Krawczynski K.

Baillieres Clin Gastroenterol. 1996 Jul;10(2):227-42. Review.

PMID:
8864031
44.

Hospital-based evaluation of programs to prevent perinatal hepatitis B virus transmission.

Yusuf HR, Mahoney FJ, Shapiro CN, Mast EE, Polish L.

Arch Pediatr Adolesc Med. 1996 Jun;150(6):593-7.

PMID:
8646308
45.

The cost of a food-borne outbreak of hepatitis A in Denver, Colo.

Dalton CB, Haddix A, Hoffman RE, Mast EE.

Arch Intern Med. 1996 May 13;156(9):1013-6.

PMID:
8624166
46.

Hepatitis E: an overview.

Mast EE, Krawczynski K.

Annu Rev Med. 1996;47:257-66. Review.

PMID:
8712780
47.

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.

Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA.

JAMA. 1995 Oct 18;274(15):1201-8.

PMID:
7563509
48.

A university outbreak of Escherichia coli O157:H7 infections associated with roast beef and an unusually benign clinical course.

Rodrigue DC, Mast EE, Greene KD, Davis JP, Hutchinson MA, Wells JG, Barrett TJ, Griffin PM.

J Infect Dis. 1995 Oct;172(4):1122-5.

PMID:
7561194
49.

Transmission of blood-borne pathogens during sports: risk and prevention.

Mast EE, Goodman RA, Bond WW, Favero MS, Drotman DP.

Ann Intern Med. 1995 Feb 15;122(4):283-5. Review.

PMID:
7825765
50.

non-ABCDE hepatitis: is there another enterically transmitted hepatitis virus?

Mast EE, Purdy MA.

Hepatology. 1995 Jan;21(1):256-7. No abstract available.

PMID:
7806162

Supplemental Content

Support Center